Magnetic Bead Virus Capture from Crude Lysate Without Filtration

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The traditional manufacturing process for biopharmaceuticals such as viral vectors and monoclonal antibodies is hindered by the need to remove solid impurities that can clog chromatography columns, and influenza and adenoviruses tend to aggregate, leading to yield loss in conventional filtration methods.

Innovation Solution

A method involving the use of magnetic beads, specifically agarose beads with embedded magnetite particles and quaternary trimethylamine (Q) or dextran sulfate (S) ligands, for direct capture of adenovirus and influenza virus from crude cell lysate, utilizing batch adsorption and magnetic separation to bypass filtration steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional filtration is used to remove solid impurities, then column blocking is prevented, but virus yield is significantly lost due to aggregation and time-consuming processing

Engineering Contradiction:

Improvecolumn blocking preventionVSAvoidvirus yield

Core Design Contradiction:

ReliabilityVSLoss of substance

Solution Approach 1:

Instead of filtering viruses out before chromatography (which causes aggregation and loss), the invention inverts the approach by using magnetic beads to capture viruses directly from crude lysate, then applying the captured viruses to chromatography columns. This reversal eliminates the need for pre-filtration and prevents virus aggregation-related losses.

Inventive Principle:

Principle #13The other way round (Inversion)

Solution Approach 2:

Magnetic beads serve as an intermediary carrier that captures viruses from crude cell lysate through specific ligand binding. This intermediary step allows viruses to be isolated and concentrated without direct filtration, preventing aggregation and enabling subsequent chromatography without column blocking issues.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Reliability

If filtration is used to remove solid impurities, then column blocking is prevented, but the process becomes time-consuming and expensive

Engineering Contradiction:

Improvecolumn blocking preventionVSAvoidprocessing time

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

The invention extracts the virus purification step from the traditional filtration-chromatography sequence. By using magnetic beads to directly capture and isolate viruses from crude lysate, the method eliminates the time-consuming filtration step while maintaining column protection through the magnetic capture-chromatography workflow.

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The invention replaces the mechanical filtration system with a magnetic field-based separation system. Magnetic beads captured by magnetic fields substitute for physical filtration membranes, eliminating the time-consuming filtration process while achieving the same goal of protecting chromatography columns from solid impurities.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

3Loss of time

If direct capture from crude lysate is attempted, then filtration steps are eliminated, but selectivity and binding capacity must be sufficiently high

Engineering Contradiction:

Improveprocess timeVSAvoidbinding selectivity

Core Design Contradiction:

Loss of timeVSManufacturing precision

Solution Approach 1:

The magnetic beads are functionalized with specific ligands (quaternary trimethylamine for adenovirus, dextran sulfate for influenza virus) that provide localized binding specificity. This local quality enhancement on the bead surface enables high-selectivity capture of target viruses from complex crude lysate, achieving up to 90% binding capacity within minutes.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The invention uses composite magnetic beads combining magnetic particles (for separation), agarose matrix (for structural stability and biocompatibility), and specific ligands (for selective binding). This composite structure enables direct capture from crude lysate with high selectivity, eliminating filtration steps while maintaining manufacturing precision.

Inventive Principle:

Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method achieves rapid and efficient virus purification with high selectivity and capacity, capturing up to 90% of target virus within minutes, thereby replacing time-consuming and costly filtration processes.

Implementation Method 1

Addition of magnetic beads to a crude cell lysate suspension comprising target virus; Capture of said magnetic beads

Methodology Applied

Scientific EffectMagnetic separation: Magnetism

Implementation Method 2

Homogenization and incubation of said suspension to allow binding of said target virus to ligands on said magnetic beads

Methodology Applied

Scientific EffectAdsorption: Adsorption

Data Source

PatentUS20250313812A1Method for virus capture

Publication Date: 2025.10.09 CYTIVA BIOPROCESS R&D AB

AI summary

The present invention relates to a method for virus capture or separation. More closely, the invention relates to a method for direct influenza and adenovirus capture using magnetic beads. The method allows direct separation from crude cell lysate in a rapid manner.